Based in Switzerland, Avelo is a startup. Brouky records 2 investors associated with the company.
Avelo is a Zurich-based diagnostics startup developing a simple breath collector to enable non-invasive, painless sampling from the lower respiratory tract for diagnosing tuberculosis and other respiratory infections; collected samples are intended to be analyzed using existing PCR testing infrastructure.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.